Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|May 2, 2002
4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitorsErik A A Wallén, Johannes A M Christiaans, Susanna M Saario, et al.
The Biochemical Journal|June 26, 2004
Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 siteJarkko I Venäläinen, Risto O Juvonen, J Arturo Garcia-Horsman, et al.
Bioorganic & Medicinal Chemistry|January 12, 2007
2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitorsElina M Jarho, Jarkko I Venäläinen, Sami Poutiainen, et al.
European Journal of Medicinal Chemistry|April 30, 2016
Synthesis, radiolabeling and evaluation of novel amine guanidine derivatives as potential positron emission tomography tracers for the ion channel of the N-methyl-d-aspartate receptorPieter J Klein, Marion Chomet, Athanasios Metaxas, et al.
Biochemical Pharmacology|January 13, 2006
Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitorsJarkko I Venäläinen, J Arturo Garcia-Horsman, Markus M Forsberg, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitorsElina M Jarho, Jarkko I Venäläinen, Juha Juntunen, et al.
Journal of Medicinal Chemistry|October 29, 2004
A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitorsElina M Jarho, Jarkko I Venäläinen, Juhani Huuskonen, et al.
Nuclear Medicine and Biology|June 16, 2014
Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[(11)C]methoxyphenyl)pyridin-3-yl)methyl)cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptorsJohannes A M Christiaans, Pieter J Klein, Athanasios Metaxas, et al.
Pharmacology Research & Perspectives|February 21, 2019
Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[3 H]3 methoxy phenyl)-N'-methylguanidine ([3 H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonistAthanasios Metaxas, Bart N M van Berckel, Pieter J Klein, et al.
Molecular Imaging and Biology|October 12, 2018
Evaluation of the Novel PET Tracer [11C]HACH242 for Imaging the GluN2B NMDA Receptor in Non-Human PrimatesJasper van der Aart, Maqsood Yaqub, Esther J M Kooijman, et al.
Pageof 3